In patients who did not develop metastases, there was a significant negative correlation between FSCN1 and miR-133a expression (Figure 2(f), γ = −0.33, P = 0.037), but no significant association was observed in patients with metastatic disease. This evidence concerns the gene FSCN1 and metastatic neoplasm.